Singular Health Advances to Phase 2 of Medical Imaging Project with PNS

Singular Health Group Ltd ( (AU:SHG) ) has shared an update.

Singular Health Group Ltd has successfully completed the technical proof of concept for Phase 1 of its Memorandum of Understanding with Provider Network Solutions (PNS). This achievement showcases the company’s ability to efficiently manage medical imaging data across remote facilities using artificial intelligence, potentially reducing duplicate imaging costs. With Phase 1 completed, Singular Health and PNS are now progressing to Phase 2, which involves detailed planning for a commercial pilot scheduled for the March quarter of 2025. This advancement signals a significant step forward in Singular Health’s collaboration with PNS, as they prepare to implement the Medical File Transfer Protocol (MFTP) across PNS’s extensive network, promising considerable savings and efficiency improvements.

More about Singular Health Group Ltd

Singular Health Group is an ASX-listed medical technology company based in Western Australia, focused on creating a seamless healthcare ecosystem through its 3Dicom software solutions. The company aims to enhance patient outcomes by unlocking the full value of medical imaging records and promoting interoperability. Its 3Dicom MD® software is approved for diagnostic use in the United States.

YTD Price Performance: 14.55%

Average Trading Volume: 1,248,866

Technical Sentiment Consensus Rating: Sell

Current Market Cap: A$61.8M

For an in-depth examination of SHG stock, go to TipRanks’ Stock Analysis page.